{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:50:51Z","timestamp":1782773451200,"version":"3.54.5"},"reference-count":26,"publisher":"Japanese Society of Internal Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018,6,1]]},"DOI":"10.2169\/internalmedicine.9736-17","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T17:19:49Z","timestamp":1515604789000},"page":"1645-1649","source":"Crossref","is-referenced-by-count":22,"title":["CV2\/CRMP5-antibody-related Paraneoplastic Optic Neuropathy Associated with Small-cell Lung Cancer"],"prefix":"10.2169","volume":"57","author":[{"given":"Masanori","family":"Nakajima","sequence":"first","affiliation":[{"name":"Department of Neurology, Faculty of Medicine, Kyorin University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Uchibori","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine, Kyorin University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine, Kyorin University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine, Kyorin University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaeko","family":"Ichikawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine, Kyorin University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimihiko","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Hospital Organization, Yonezawa Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tohoku Medical and Pharmaceutical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Shiraishi","sequence":"additional","affiliation":[{"name":"Department of Neurology and Strokology, Nagasaki University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakatsu","family":"Motomura","sequence":"additional","affiliation":[{"name":"Medical Engineering Course, Department of Engineering, Faculty of Engineering, Nagasaki Institute of Applied Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuro","family":"Chiba","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine, Kyorin University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Voltz R. Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy. Lancet Neurol 1: 293-305, 2002.","DOI":"10.1016\/S1474-4422(02)00135-7"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Honnorat J, Antoine JC. Paraneoplastic neurological syndromes. Orphanet J Rare Dis 2: 22-31, 2007.","DOI":"10.1186\/1750-1172-2-22"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75: 1135-1140, 2004.","DOI":"10.1136\/jnnp.2003.034447"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Damek DM. Paraneoplastic retinopathy\/ optic neuropathy. Curr Treat Options Neurol 7: 57-67, 2005.","DOI":"10.1007\/s11940-005-0007-1"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Pillay N, Gilbert JJ, Ebers GC, Brown JD. Internuclear ophthalmoplegia and &quot;optic neuritis&quot;: paraneoplastic effects of bronchial carcinoma. Neurology 34: 788-791, 1984.","DOI":"10.1212\/WNL.34.6.788"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Cross SA, Salomao DR, Parisi JE, et al. Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG. Ann Neurol 54: 38-50, 2003.","DOI":"10.1002\/ana.10587"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Yu Z, Kryzer TJ, Griesmann GE, et al. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 49: 146-154, 2001.","DOI":"10.1002\/1531-8249(20010201)49:2<146::AID-ANA34>3.0.CO;2-E"},{"key":"8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/01658109109036976","volume":"11","author":"A Oohira","year":"1991","unstructured":"8. Oohira A, Inoue T, Fukuda N, Uchida K. A case with paraneoplastic optic neuropathy presenting bitemporal hemianopsia. Neuro-Ophthalmology 11: 325-328, 1991.","journal-title":"Neuro-Ophthalmology","ISSN":"https:\/\/id.crossref.org\/issn\/0165-8107","issn-type":"print"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kuroda Y, Miyahara M, Sakemi T, et al. Autopsy report necrotizing opticomyelopathy associated with thyroid cancer. J Neurol Sci 120: 29-32, 1993.","DOI":"10.1016\/0022-510X(93)90020-Y"},{"key":"10","unstructured":"10. Kusakabe K, Ikeda H, Mizota A. Two cases of presumed paraneoplastic optic neuropathy. Ganka Rinsho Iho (Japanese Review of Clinical Ophthalmology) 88: 1354-1357, 1994 (in Japanese)."},{"key":"11","unstructured":"11. Mochizuki Y, Minzutani T, Ishikawa H, et al. An autopsy case of paraneoplastic optic neuropathy as acomplication of lung cancer. Neuropathology 19: A43, 1999."},{"key":"12","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/sj.eye.6702730","volume":"21","author":"Y Murakami","year":"2007","unstructured":"12. Murakami Y, Yoshida S, Yoshikawa H, et al. CRMP-5-IgG in patient with paraneoplastic optic neuritis with lung adenocarcinoma. Eye 21: 860-862, 2007.","journal-title":"Eye","ISSN":"https:\/\/id.crossref.org\/issn\/0078-5334","issn-type":"print"},{"key":"13","unstructured":"13. Furuta Y, Nakamura M, Kumagai A, et al. A case of presumed paraneoplastic optic neuropathy. Atarashii Ganka (Journal of the Eye) 25: 1167-1172, 2008 (in Japanese, Abstract in English)."},{"key":"14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2415-14-5","volume":"14","author":"M Saito","year":"2014","unstructured":"14. Saito M, Saito W, Kanda A, Ohguro H, Ishida S. A case of paraneoplastic optic neuropathy and outer retinitis positive for autoantibodies against collapsin response mediator protein-5, recoverin, and \u03b1-enolase. BMC Ophthalmology 14: 5, 2014.","journal-title":"BMC Ophthalmology","ISSN":"https:\/\/id.crossref.org\/issn\/1471-2415","issn-type":"print"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Honnarat J, Antoine JC, Derrington E, et al. Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 61: 270-278, 1996.","DOI":"10.1136\/jnnp.61.3.270"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Charrier E, Reibel S, Rogemond V, et al. Collapsin response mediator proteins (CRMPs): involvement in nervous system development and adult neurodegenerative disorders. Mol Neurobiol 28: 51-64, 2003.","DOI":"10.1385\/MN:28:1:51"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Rauer S, Kaiser R. Demonstration of anti-HuD specific oligoclonal bands in the cerebrospinal fluid from patients with paraneoplastic neurological syndromes. Qualitative evidence of anti-HuD specific IgG synthesis in the central nervous system. J Neuroimmunol 111: 241-244, 2000.","DOI":"10.1016\/S0165-5728(00)00391-X"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Stich O, Graus F, Rasiah C, Rauer S. Qualitative evidence of anti-Yo-specific intrathecal antibody synthesis in patients with paraneoplastic cerebellar degeneration. J Neuroimmunol 141: 165-169, 2003.","DOI":"10.1016\/S0165-5728(03)00257-1"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Jarius S, Arnold S, Linke R, et al. Long term survival in anti-Hu associated adult neuroblastoma. J Neurol Sci 284: 205-208, 2009.","DOI":"10.1016\/j.jns.2009.04.007"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Tanaka M, Tanaka K, Tokiguchi S, Shinozawa K, Tsuji S. Cytotoxic T cells against a peptide of Yo protein in patients with paraneoplastic cerebellar degeneration and anti-Yo antibody. J Neurol Sci 168: 28-31, 1999.","DOI":"10.1016\/S0022-510X(99)00163-X"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Tanaka M, Maruyama Y, Sugie M, Motizuki H, Kamakura K, Tanaka K. Cytotoxic T cell activity against peptides of Hu protein in anti-Hu syndrome. J Neurol Sci 201: 9-12, 2002.","DOI":"10.1016\/S0022-510X(02)00157-0"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Sato DK, Callegaro D, Lana-Peixoto MA, et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 82: 474-481, 2014.","DOI":"10.1212\/WNL.0000000000000101"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Nakajima H, Motomura M, Tanaka K, et al. Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis. BMJ Open 5: e007766, 2015.","DOI":"10.1136\/bmjopen-2015-007766"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Rahimy E, Sarraf D. Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: Evaluation and management. Surv Ophthalmol 58: 430-458, 2013.","DOI":"10.1016\/j.survophthal.2012.09.001"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Keime-Guibert F, Graus F, Fleury A, et al. Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol Neurosurg Psychiatry 68: 479-482, 2000.","DOI":"10.1136\/jnnp.68.4.479"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Vernino S, O&apos;Neill BP, Marks RS, O&apos;Fallon JR, Kimmel DW. Immunomodulatory treatment trial for paraneoplastic neurological disorders. Neuro Oncol 6: 55-62, 2004.","DOI":"10.1215\/S1152851703000395"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/11\/57_9736-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,6,2]],"date-time":"2018-06-02T00:05:35Z","timestamp":1527897935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/11\/57_9736-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9736-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,1]]}}}